Agape ATP Corporation ATPC
2.24
0.00
0.00%
as of 25 Sep
- Market cap
- $2.3M
- P/E
- 1.6×
Follow ATPC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
2.17 | 3.69 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.25 | 1.74 | 2.81 | 51.58 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(26.85) | (6.67) | (20.58) | (246.33) | |
P/B ratio |
0.13 | 0.12 | 0.19 | 2.77 | |
Price to Tangible BV |
0.13 | 0.12 | 0.19 | 2.78 | |
EV/Sales |
2.24 | 1.66 | 2.78 | 51.55 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(3.04) | (1.85) | (1.76) | (22.18) | |
EV/FCF |
(3.03) | (1.85) | (1.75) | (22.16) | |
Quick Ratio |
0.02 | 0.08 | 0.05 | 0.10 | |
Current Ratio |
8.45 | 9.01 | 11.82 | 16.21 | |
Net Debt/EBITDA |
0.02 | 0.19 | 0.04 | 0.05 | |
Debt/Assets |
0.13% | 0.39% | 0.16% | 0.43% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.05 | 0.06 | 0.11 | 0.09 | |
Operating CF/Net income |
(0.72) | 1.21 | 0.57 | 0.43 | |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | (0.03) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4,082.48% | 303.95% | 253.74% | 219.37% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
7.38 | 8.29 | 5.16 | 0.36 | |
Graham Number |
26.00 | 18.81 | 0.00 | 0.00 | |
Earnings Yield |
46.04% | 27.11% | (45.93%) | (22.92%) | |
Free Cash Flow Yield |
(32.81%) | (51.53%) | (56.35%) | (4.51%) | |
Revenue per Share |
0.01 | 0.27 | 0.82 | 0.37 | |
Operating CF per Share |
(0.11) | (0.39) | (0.26) | (0.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.11) | (0.39) | (0.26) | (0.26) | |
Cash per Share |
0.05 | 0.22 | 0.11 | 0.13 | |
Shareholders Equity per Share |
22.04 | 22.06 | 27.99 | 22.80 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.04 | 22.06 | 27.99 | 22.80 | |
Free Cash Flow |
(0.11) | (0.39) | (0.21) | (0.26) | |
Working Capital |
21.90 | 21.92 | 22.24 | 22.59 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
21.86 | 21.82 | 22.13 | 22.48 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
1,116.79% | (119.69%) | (56.02%) | (160.66%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.01 | 0.03 | 0.03 | 0.03 | |
Average Payables |
— | 0.12 | 0.14 | 0.12 | |
Average Inventory |
0.03 | 0.03 | 0.04 | 0.05 | |
Average Assets |
24.87 | 25.05 | 13.92 | 14.18 | |
Average Common Equity |
22.73 | 23.05 | 12.18 | 12.78 |
Columns are period end dates